Literature DB >> 6692402

Alteration of cell shape, adhesion, and lipid accumulation in human breast cancer cells (T-47D) by human prolactin and growth hormone.

R P Shiu, J A Paterson.   

Abstract

We have demonstrated previously that many human cancer cell lines maintained in tissue culture possess specific cell surface receptors for human prolactin (HPRL) and human growth hormone (HGH). In the present studies, the biological response in vitro of one human breast cancer cell line, T-47D, to the two pituitary hormones was examined. T-47D cells, when grown on tissue culture dishes, display typical epithelioid characteristics; cells are flat and polygonal in shape and are very adhesive to the plastic substratum. Upon the addition of HPRL or HGH (10 to 1000 ng/ml), in the presence of hydrocortisone, insulin, and triiodothyronine, each at 1 microgram/ml, the T-47D cells became round and refractile. In addition, there was a dramatic reduction in the adhesiveness of the cells to the substratum; 80% of the hormone-treated cells were detached by trypsin (25 micrograms/ml) in 30 min at 37 degrees, as compared with 5% for cells not treated with hormones. These prolactin-induced changes could be abolished upon the addition of antiserum to prolactin. Neither HPRL nor the combination of hydrocortisone, insulin, and triiodothyronine alone was active, indicating a synergism between HPRL and hydrocortisone, insulin, and triiodothyronine. It was subsequently found that only hydrocortisone was required for the action of HPRL, and that human luteininzing hormone and ovine growth hormone were inactive, whereas ovine prolactin exerted a very weak effect. In addition, in the presence of hydrocortisone (or hydrocortisone, insulin, and triiodothyronine), HPRL (or HGH) retarded cell proliferation by 30%, whereas HPRL or hydrocortisone by itself had no effect on cell growth. Ultrastructural studies revealed that, accompanying cell rounding and reduced adhesion, HPRL and HGH increased the formation of intracytoplasmic lipid droplets in the T-47D cells. The increase in lipid synthesis was confirmed by the staining of cells with Oil Red O, and by monitoring the incorporation of [14C]acetate into lipid; HPRL stimulated lipid synthesis and accumulation by approximately 2-fold. Thus, receptor-positive human breast cancer cells are biologically responsive in vitro to HPRL and HGH.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6692402

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

Review 1.  Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention.

Authors:  Lisa M Butler; Ylenia Perone; Jonas Dehairs; Leslie E Lupien; Vincent de Laat; Ali Talebi; Massimo Loda; William B Kinlaw; Johannes V Swinnen
Journal:  Adv Drug Deliv Rev       Date:  2020-07-23       Impact factor: 15.470

2.  Influence of time and osmolarity on nuclear area of tumor cells growing in vitro.

Authors:  M Volk; C Arncken; H Naujoks
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

3.  Specific unsaturated fatty acids enforce the transdifferentiation of human cancer cells toward adipocyte-like cells.

Authors:  Antonio Ruiz-Vela; Cristóbal Aguilar-Gallardo; Ana M Martínez-Arroyo; Mario Soriano-Navarro; Verónica Ruiz; Carlos Simón
Journal:  Stem Cell Rev Rep       Date:  2011-11       Impact factor: 5.739

4.  Cyclin E Associates with the Lipogenic Enzyme ATP-Citrate Lyase to Enable Malignant Growth of Breast Cancer Cells.

Authors:  Kimberly S Lucenay; Iman Doostan; Cansu Karakas; Tuyen Bui; Zhiyong Ding; Gordon B Mills; Kelly K Hunt; Khandan Keyomarsi
Journal:  Cancer Res       Date:  2016-02-29       Impact factor: 12.701

Review 5.  Cell-contact and -architecture of malignant cells and their relationship to metastasis.

Authors:  A Raz; A Ben-Ze'ev
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

6.  Growth hormone receptor is expressed in human breast cancer.

Authors:  M Gebre-Medhin; L G Kindblom; H Wennbo; J Törnell; J M Meis-Kindblom
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

7.  Prolactin stimulates the JAK2 and focal adhesion kinase pathways in human breast carcinoma T47-D cells.

Authors:  E Canbay; M Norman; E Kilic; V Goffin; I Zachary
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

8.  Phosphorylation of tyrosine 285 of PAK1 facilitates βPIX/GIT1 binding and adhesion turnover.

Authors:  Alan Hammer; Peter Oladimeji; Luis E De Las Casas; Maria Diakonova
Journal:  FASEB J       Date:  2014-12-02       Impact factor: 5.191

Review 9.  Tyrosyl phosphorylated serine-threonine kinase PAK1 is a novel regulator of prolactin-dependent breast cancer cell motility and invasion.

Authors:  Alan Hammer; Maria Diakonova
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

10.  Involvement of cell shape and lipid metabolism in glioblastoma resistance to temozolomide.

Authors:  Munki Choo; Van-Hieu Mai; Han Sun Kim; Dong-Hwa Kim; Ja-Lok Ku; Sang Kook Lee; Chul-Kee Park; Yong Jin An; Sunghyouk Park
Journal:  Acta Pharmacol Sin       Date:  2022-09-13       Impact factor: 7.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.